Amrize Ltd (AMRZ)vsTitan America SA (TTAM)
AMRZ
Amrize Ltd
$40.52
+0.20%
BASIC MATERIALS · Cap: $23.97B
TTAM
Titan America SA
$14.60
-0.54%
BASIC MATERIALS · Cap: $2.85B
Smart Verdict
WallStSmart Research — data-driven comparison
Amrize Ltd generates 612% more annual revenue ($12.18B vs $1.71B). TTAM leads profitability with a 10.3% profit margin vs 10.1%. TTAM trades at a lower P/E of 16.1x. AMRZ earns a higher WallStSmart Score of 68/100 (B-).
AMRZ
Strong Buy68
out of 100
Grade: B-
TTAM
Hold47
out of 100
Grade: D+
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Strong operational efficiency at 20.5%
Attractively priced relative to earnings
Reasonable price relative to book value
Areas to Watch
Distress zone — elevated risk
Weak financial health signals
Earnings declined 17.1%
Comparative Analysis Report
WallStSmart ResearchBull Case : AMRZ
The strongest argument for AMRZ centers on Price/Book, Operating Margin. PEG of 1.13 suggests the stock is reasonably priced for its growth.
Bull Case : TTAM
The strongest argument for TTAM centers on P/E Ratio, Price/Book.
Bear Case : AMRZ
The primary concerns for AMRZ are Altman Z-Score, Piotroski F-Score.
Bear Case : TTAM
The primary concerns for TTAM are EPS Growth.
Key Dynamics to Monitor
TTAM is growing revenue faster at 9.6% — sustainability is the question.
AMRZ generates stronger free cash flow (173M), providing more financial flexibility.
Monitor BUILDING MATERIALS industry trends, competitive dynamics, and regulatory changes.
Bottom Line
AMRZ scores higher overall (68/100 vs 47/100). Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Amrize Ltd
BASIC MATERIALS · BUILDING MATERIALS · USA
Amrize Ltd (AMRZ) is an innovative technology firm at the forefront of the digital health and wellness industry, dedicated to transforming healthcare delivery with cutting-edge technologies and data-driven solutions. The company prioritizes enhancing patient outcomes and access to care, significantly investing in research and development to address the rising demand for scalable health innovations. With a diverse portfolio of products and strategic initiatives, Amrize is well-positioned to become a critical player in the ongoing evolution of healthcare, presenting a compelling investment opportunity for institutional investors navigating a dynamic market.
Visit Website →Titan America SA
BASIC MATERIALS · BUILDING MATERIALS · USA
Titan America SA (TTAM) is a leading entity in the U.S. cement and construction materials sector, distinguished for its commitment to sustainability and innovation. The company operates strategically located facilities that optimize distribution, catering to the increasing demand driven by robust infrastructure investments across the country. By focusing on advanced technologies to enhance production efficiency, Titan America maintains a strong competitive advantage. As the construction industry adapts to evolving needs, TTAM is positioned for significant growth and sustained success in a dynamic marketplace.
Compare with Other BUILDING MATERIALS Stocks
Want to dig deeper into these stocks?